Literature DB >> 16434276

Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation.

Philip A Linden1, Richard J Gilbert, Beow Y Yeap, Kathleen Boyle, Aaron Deykin, Michael T Jaklitsch, David J Sugarbaker, Raphael Bueno.   

Abstract

OBJECTIVE: There is a strong association between reflux and end-stage lung disease, especially idiopathic pulmonary fibrosis. The presence of reflux after lung transplantation might predispose to the development of bronchiolitis obliterans. We evaluated the risk and physiologic effect of laparoscopic fundoplication in patients on the lung transplant waiting list.
METHODS: One hundred forty-nine patients on the lung transplant waiting list between March 2001 and January 2005 were evaluated. Nineteen were found to have a history of reflux, continued symptoms, and severe reflux by means of pH and manometric studies and underwent laparoscopic fundoplication. The postoperative course of these 19 patients, including lung function, was retrospectively reviewed. Postoperatively, the lung function of the 14 patients with idiopathic pulmonary fibrosis who underwent the laparoscopic Nissen procedure was compared with that of 31 patients with idiopathic pulmonary fibrosis on the transplant waiting list who did not undergo fundoplication.
RESULTS: There were no perioperative complications and no decrease in lung function over the 15-month average follow-up. Exercise capacity remained stable, as determined on the basis of 6-minute walk distance. Patients with idiopathic pulmonary fibrosis treated with fundoplication had stable oxygen requirements, whereas control patients with idiopathic pulmonary fibrosis on the waiting list had a statistically significant deterioration in oxygen requirement.
CONCLUSIONS: Laparoscopic fundoplication can be performed safely in patients with end-stage lung disease awaiting lung transplantation. Overall, these patients maintained stable lung function during the follow-up period. When compared with a control group of patients with idiopathic pulmonary fibrosis not undergoing fundoplication, there was stabilization of oxygen requirement. A larger prospective trial evaluating the effect of laparoscopic fundoplication on underlying lung function in this patient population is warranted.

Entities:  

Mesh:

Year:  2006        PMID: 16434276     DOI: 10.1016/j.jtcvs.2005.10.014

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  48 in total

Review 1.  A review of the potential applications and controversies of non-invasive testing for biomarkers of aspiration in the lung transplant population.

Authors:  C S Davis; J Gagermeier; D Dilling; C Alex; E Lowery; E J Kovacs; R B Love; P M Fisichella
Journal:  Clin Transplant       Date:  2010-03-19       Impact factor: 2.863

2.  Laparoscopic repair of a gastric volvulus occurring as a long-term complication of left pneumonectomy: report of a case.

Authors:  Hasan Fevzi Batirel; Oya Uygur-Bayramicli; Sevgi Guler; Bedrettin Yildizeli; Mustafa Yuksel
Journal:  Surg Today       Date:  2007-01-01       Impact factor: 2.549

3.  Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: flip side of the story.

Authors:  Yohannes T Ghebre
Journal:  Inflamm Cell Signal       Date:  2016-08-22

4.  Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis.

Authors:  Joyce S Lee; Jay H Ryu; Brett M Elicker; Carmen P Lydell; Kirk D Jones; Paul J Wolters; Talmadge E King; Harold R Collard
Journal:  Am J Respir Crit Care Med       Date:  2011-06-23       Impact factor: 21.405

5.  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Authors:  Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2011-03-15       Impact factor: 21.405

6.  Surgical correction of gastroesophageal reflux in lung transplant patients is associated with decreased effector CD8 cells in lung lavages: a case series.

Authors:  David C Neujahr; Aminu Mohammed; Onome Ulukpo; Seth D Force; Allan M Ramirez; Andres Pelaez; E Clinton Lawrence; Christian P Larsen; Allan D Kirk
Journal:  Chest       Date:  2010-06-03       Impact factor: 9.410

7.  The Intersection of GERD, Aspiration, and Lung Transplantation.

Authors:  Marco G Patti; Marcelo F Vela; David D Odell; Joel E Richter; P Marco Fisichella; Michael F Vaezi
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2016-05-24       Impact factor: 1.878

8.  Symptomatic gastroesophageal reflux disease after lung transplantation.

Authors:  Ezequiel J Molina; Scott Short; Glen Monteiro; John P Gaughan; Mahender Macha
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-12

Review 9.  New therapeutic targets in idiopathic pulmonary fibrosis. Aiming to rein in runaway wound-healing responses.

Authors:  Neil Ahluwalia; Barry S Shea; Andrew M Tager
Journal:  Am J Respir Crit Care Med       Date:  2014-10-15       Impact factor: 21.405

Review 10.  The pulmonary side of reflux disease: from heartburn to lung fibrosis.

Authors:  Marco E Allaix; P Marco Fisichella; Imre Noth; Bernardino M Mendez; Marco G Patti
Journal:  J Gastrointest Surg       Date:  2013-04-25       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.